1.
Eichenfeld L, Siegfried E, Kwong P, Cutler S, Willson C, Rumney P, Crosby C, Andres J, McBride M. Proportion of Subjects Achieving a Molluscum Lesion Count of 0 or 1 at the Day 84 End of Study Visit in Phase 3 Clinical Trials with VP-102 CAMP-1 and CAMP-2. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.13];5(6):s92. Available from: https://jofskin.org/index.php/skin/article/view/1443